期刊文献+

紫杉醇或培美曲塞联合顺铂治疗晚期非小细胞肺癌的疗效观察 被引量:8

下载PDF
导出
摘要 目的比较紫杉醇或培美曲塞联合顺铂治疗晚期非小细胞肺癌(NSCLC)的临床疗效及毒副作用。方法将33例晚期NSCLC随机分为紫杉醇加顺铂组(TC)17例和培美曲塞加顺铂组(PC)16例。TC组紫杉醇85mg/m2,d1、8;顺铂75mg/m2,d1~3。PC组培美曲塞500mg/m2,d1;顺铂75mg/m2,d1~3,两组均为每21d一个周期重复。结果紫杉醇加顺铂组和培美曲塞加顺铂组有效率分别为52.9%和50.0%,两组之间有效率无统计学意义(P>0.05)。培美曲塞加顺铂组粒细胞减少的发生率小于紫杉醇加顺铂组。结论培美曲塞联合顺铂治疗晚期非小细胞肺癌的疗效与紫杉醇加顺铂的疗效相当,但副作用明显减少,可以作为临床一线治疗。
作者 郭依龙
出处 《齐齐哈尔医学院学报》 2010年第16期2549-2550,共2页 Journal of Qiqihar Medical University
  • 相关文献

参考文献13

  • 1王朝霞,王继荣,王莉,王娟,王科明.紫杉醇联合奥沙利铂与紫杉醇联合顺铂治疗老年晚期非小细胞肺癌疗效观察(附72例)[J].现代肿瘤医学,2009,17(11):2134-2136. 被引量:6
  • 2Pirker R,MinarW.Chemotherapy of advanced non-small cellLung cancer[J].Front Radiat Ther Oncol,2010,42:157-163.
  • 3Rollins KD,Lindley C.Pemetrexed:amultitargeted antifolate[J].Clin Ther,2005,27(9):1343-82.
  • 4Mackae R,Choy H.Concurrent chemotherapy for inoperable stage Ⅲ non-small cell lung cancer[J].Curr Oncol Rep,2003,5(4):313-317.
  • 5Kawahara M,Kris MG,Green M,et al.New drug and multimo-dality combinations in treatment of advanced non small cell lung cancer[J].Sem in Oncol,2001,28(3 Suppl 9):1-4.
  • 6Manegold C,Gatzemeier U,von Pawel J,et al.Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514,pemetrexed disodium,ALIMTA) and cisplatin:a multicenter phase II trial[J].Ann Oncol,2000,11(4):435-440.
  • 7孙燕 周际昌.临床肿瘤内科手册[M].北京:人民卫生出版社,2003.586-591.
  • 8Rollins KD,Lindley C.Pemetrexed:amultitargeted antifolate[J].Clin Ther,2005,27(9):1343.
  • 9Manegold C,Gatzemeier U,von Pawel J,et al.Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514,pemetrexed disodium,ALIMTA) and cisplatin:a multicenter phase II trial[J].Ann Oncol,2000,11(4): 435-440.
  • 10Shepherd FA,Dancey J,Arnold A,et al.Phase II study of pemetrexed disodium,a multitargeted antifolate,and cisplatin as first-line therapy in patientswith advanced non-small cell lung carcinoma[J].Cancer (Phila),2001,92(3):595-600.

二级参考文献10

  • 1程中伟,张力.老年人晚期非小细胞肺癌化疗新进展[J].中国医学科学院学报,2004,26(3):330-334. 被引量:19
  • 2Parkin DM. Global cancer statistics in the year 2000[ J]. Lancet Oncol,2001,2(9) : 533 -543.
  • 3Waller D, Peake MD, Stephens R J, et al. Chemotherapy for patients with non - small cell lung cancer: the surgical setting of the Big Lung Trial[ J ]. Eur J Cardiothorac Surg,2004,26 ( 1 ) : 173 - 182.
  • 4Langer C J, Manola J, Bernardo P, et al. Cisplatin - based therapy for elderly patients with advanced non - small - cell lung cancer: implications of eastern cooperative oncology group 5592, a randomized trial[J]. J Natl Cancer Inst,2002,94 ( 3 ) : 173 - 181.
  • 5Lilenbaum RC, Hemdon JE 2nd, List MA, et al. Single -agent versus combination chemotherapy in advanced non - small - cell lung cancer : the cancer and leukemia group B ( study 9730) [ J ]. J Clin Onco1,2005,23 ( 1 ) : 190 - 196.
  • 6Seidman AD, Hudis CA, Albanell J, et al. Dose - dense therapy with weekly 1 - hour paclitaxel infusions in the treatment of metastatic breast cancer[J].J Clin Oncol, 1998,16 ( 10 ) : 3353 - 3361.
  • 7Rowinsky EK, Jiroutek M, Bonomi P, et al. oxaliplatin steadystate plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin [J]. Clin Cancer Res ,1999,5(4) :767 -774.
  • 8Perez EA, Vogel CL, Irwin DH, et al. Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer[ J]. J Clin Oncol,2001,19 (22) :4216 -4223.
  • 9Monnet I, Brienza S, Hugret F, et al. Phase II study of oxaliplatin in poor - prognosis non - small cell lung cancer ( NSCLC ). AT- TIT. Association pour le Traitement des Tumeurs Intra Thora- ciques [J]. Eur J Cancer, 1998,34 (7) : 1124 - 1127.
  • 10Winegarden JD, Mauer AM, Otterson GA, et al. A phase II study of oxaliplatin and paclitaxel in patients with advanced non - small - cell lung cancer[ J]. Ann Oncol,2004,15 (6) :915 - 920.

共引文献415

同被引文献27

引证文献8

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部